{"organizations": [], "uuid": "abd9365e9d2d0ef78694bdea6c8fc33664c87fc8", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027/page/8", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/03/27/pr-newswire-pre-market-technical-scan-on-health-care-plans-equities--centene-cigna-cvs-health-and-express-scripts.html", "country": "US", "domain_rank": 767, "title": "Pre-Market Technical Scan on Health Care Plans Equities -- Centene, Cigna, CVS Health, and Express Scripts", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.04, "site_type": "news", "published": "2018-03-27T14:30:00.000+03:00", "replies_count": 0, "uuid": "abd9365e9d2d0ef78694bdea6c8fc33664c87fc8"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/03/27/pr-newswire-pre-market-technical-scan-on-health-care-plans-equities--centene-cigna-cvs-health-and-express-scripts.html", "ord_in_thread": 0, "title": "Pre-Market Technical Scan on Health Care Plans Equities -- Centene, Cigna, CVS Health, and Express Scripts", "locations": [], "entities": {"persons": [], "locations": [{"name": "new york", "sentiment": "none"}, {"name": "missouri", "sentiment": "none"}, {"name": "st. louis", "sentiment": "none"}], "organizations": [{"name": "cigna", "sentiment": "negative"}, {"name": "centene", "sentiment": "negative"}, {"name": "cvs health", "sentiment": "negative"}, {"name": "express scripts holding co.", "sentiment": "none"}, {"name": "cvs", "sentiment": "none"}, {"name": "wallstequities.com", "sentiment": "none"}, {"name": "cigna corp.", "sentiment": "none"}, {"name": "cnc", "sentiment": "none"}, {"name": "nyse", "sentiment": "none"}, {"name": "centene corp.", "sentiment": "none"}, {"name": "cvs health corp.", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "NEW YORK, March 27, 2018 /PRNewswire/ --\nWallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports on CNC, CI, CVS, and ESRX which can be accessed for free by signing up to www.wallstequities.com/registration . This morning, WallStEquities.com covers the recent performance of Centene Corp. (NYSE: CNC), Cigna Corp. (NYSE: CI), CVS Health Corp. (NYSE: CVS), and Express Scripts Holding Co. (NASDAQ: ESRX). These companies operate in the Health Care Plans space, which offers health benefit plans to employers and individuals. All you have to do is sign up today for this free limited time offer by clicking the link below.\nwww.wallstequities.com/registration\nCentene\nOn Monday, shares in St. Louis, Missouri headquartered Centene Corp. recorded a trading volume of 1.34 million shares. The stock ended the session 0.23% higher at $101.70. The Company's shares have gained 1.24% in the last month and 47.97% over the past year. The stock is trading 8.01% above its 200-day moving average. Moreover, shares of Centene, which operates as a diversified and multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the US, have a Relative Strength Index (RSI) of 44.50.\nOn March 23 rd , 2018, Centene issued a reminder that it will release its Q1 2018 financial results on April 24 th , 2018, at approximately 6:00 a.m. ET. Michael F. Neidorff, Chairman and CEO, and Jeffrey A. Schwaneke, Executive Vice President and CFO, will host a conference call at approximately 8:30 a.m. ET that same day to review the results. Get the full research report on CNC for free by clicking below at: www.wallstequities.com/registration/?symbol=CNC\nCigna\nBloomfield, Connecticut headquartered Cigna Corp.'s stock closed the day 2.85% higher at $168.68. A total volume of 3.10 million shares was traded, which was above their three months average volume of 2.30 million shares. The Company's shares have advanced 15.68% over the past year. The stock is trading 10.75% below its 200-day moving average. Additionally, shares of Cigna, which provides insurance and related products and services in the US and internationally, have an RSI of 33.50.\nOn March 13 th , 2018, research firm Bernstein initiated a 'Market Perform' rating on the Company's stock, with a target price of $194 per share.\nOn March 13 th , 2018, Cigna announced that it is entering the voice control space with the launch of \"Answers by Cigna\" skill for Amazon Alexa. The new, hands-free skill is designed to demystify language about health care by providing instant and easy-to-understand answers to more than 150 commonly-asked health care questions. Cigna is the first global health service company to offer a skill aimed at personalizing and simplifying health benefits information. Free research on CI can be accessed at: www.wallstequities.com/registration/?symbol=CI\nCVS Health\nShares in Woonsocket, Rhode Island headquartered CVS Health Corp. recorded a trading volume of 7.50 million shares. The stock ended yesterday's trading session 1.22% higher at $61.60. The Company's shares are trading below their 50-day moving average by 14.36%. Furthermore, shares of CVS Health, which together with its subsidiaries, provides integrated pharmacy health care services, have an RSI of 23.22.\nOn February 27 th , 2018, research firm Bank of America/ Merrill resumed its 'Buy' rating on the Company's stock.\nOn March 20 th , 2018, CVS Health (CVS) announced that Derica W. Rice will join the Company as President of CVS Caremark, CVS' pharmacy benefit management (PBM) business, as of March 30 th , 2018. In this role, Mr. Rice will have day-to-day leadership and oversight of the PBM business, including sales and account management, operations, mail service pharmacy, and specialty pharmacy. Visit WallStEquities.com now and sign up for the free research on CVS at: www.wallstequities.com/registration/?symbol=CVS\nExpress Scripts Holding\nSaint Louis, Missouri headquartered Express Scripts Holding Co.'s stock finished Monday's session 2.19% higher at $71.70. A total volume of 7.58 million shares was traded, which was above their three months average volume of 5.14 million shares. The Company's shares have advanced 11.84% over the past year. The stock is trading above its 200-day moving average by 7.03%. Additionally, shares of Express Scripts, which operates as a pharmacy benefit management company in the US and Canada, have an RSI of 39.08.\nOn March 12 th , 2018, research firm Bernstein upgraded the Company's stock rating from 'Underperform' to 'Market Perform'.\nOn March 14 th , 2018, Express Scripts announced that IT cancelled its previously announced investor day meeting, which was scheduled for May 02 nd , 2018, at 8:00 a.m. ET at The Roosevelt Hotel in New York. The cancellation is due to the recent announcement that the Company and Cigna Corp. have entered into an agreement and plan of merger. The free technical report on ESRX is available at: www.wallstequities.com/registration/?symbol=ESRX\n--\nWall St. Equities :\nWall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.\nWSE has not been compensated; directly or indirectly; for producing or publishing this document.\nPRESS RELEASE PROCEDURES :\nThe non-sponsored content contained herein has been prepared by a writer (the \"Author\") and is fact checked and reviewed by a third-party research service company (the \"Reviewer\") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@wallstequities.com . Rohit Tuli, a CFAÂ® charterholder (the \"Sponsor\"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.\nNO WARRANTY\nWSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.\nNOT AN OFFERING\nThis document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit https://wallstequities.com/legal-disclaimer/\nCONTACT\nFor any questions, inquiries, or comments reach out to us directly. If you're a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:\nEmail: info@wallstequities.com\nPhone number: +21-32-044-483\nOffice Address: 1 Scotts Road #24-10, Shaw Center Singapore 228\nCFAÂ® and Chartered Financial AnalystÂ® are registered trademarks owned by CFA Institute.\nView original content: http://www.prnewswire.com/news-releases/pre-market-technical-scan-on-health-care-plans-equities----centene-cigna-cvs-health-and-express-scripts-300620012.html\nSOURCE Wall St. Equities", "external_links": ["http://www.wallstequities.com/registration/?symbol=CI", "https://wallstequities.com/legal-disclaimer/", "http://www.wallstequities.com/registration/?symbol=CVS", "http://www.wallstequities.com/registration/?symbol=ESRX", "http://www.prnewswire.com/news-releases/pre-market-technical-scan-on-health-care-plans-equities----centene-cigna-cvs-health-and-express-scripts-300620012.html", "http://www.wallstequities.com/registration/?symbol=CNC", "http://www.wallstequities.com/registration"], "published": "2018-03-27T14:30:00.000+03:00", "crawled": "2018-03-27T17:41:53.024+03:00", "highlightTitle": ""}